CymitQuimica logo
Angiogenesis

Angiogenesis

Angiogenesis inhibitors are compounds that interfere with the formation of new blood vessels, a process critical in cancer growth and metastasis. By inhibiting angiogenesis, these compounds can restrict the blood supply to tumors, slowing or halting their growth. Angiogenesis inhibitors are essential in cancer research and therapeutic development, providing insights into the mechanisms of tumor progression and offering potential treatments for cancer and other angiogenesis-related diseases. At CymitQuimica, we offer a wide range of high-quality angiogenesis inhibitors to support your research in oncology and vascular biology.

Subcategories of "Angiogenesis"

Show 6 more subcategories

Found 1414 products of "Angiogenesis"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • Afatinib D6

    CAS:
    <p>Afatinib D6 (BIBW 2992 D6) is a deuterium-labeled Afatinib. Afatinib is an irreversible EGFR family inhibitor.</p>
    Formula:C24H25ClFN5O3
    Color and Shape:Solid
    Molecular weight:491.98
  • Aflibercept

    CAS:
    <p>Aflibercept has a wide range of applications in life science related research.</p>
    Color and Shape:Liquid
  • KG-548

    CAS:
    <p>KG-548 is a dual inhibitor of ARNT/TACC3 and HIF-1α, inhibiting lactate production, and can be used in cancer research.</p>
    Formula:C9H4F6N4
    Purity:99.62%
    Color and Shape:Solid
    Molecular weight:282.15
  • SM1-71

    CAS:
    <p>SM1-71 is a TAK1 inhibitor that inhibits MKNK2 and RSK2.SM1-71 acts as a kinase probe with anticancer activity.</p>
    Formula:C24H26ClN7O
    Purity:96%
    Color and Shape:Solid
    Molecular weight:463.96
  • Regorafenib-d3

    CAS:
    <p>Regorafenib D3 is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor inhibitor of tyrosine kinase.</p>
    Formula:C21H15ClF4N4O3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:485.83
  • Itacitinib adipate

    CAS:
    <p>Itacitinib adipate: oral JAK1 inhibitor, tested in phase II myelofibrosis trial.</p>
    Formula:C32H33F4N9O5
    Color and Shape:Solid
    Molecular weight:699.66
  • BI-3663

    CAS:
    <p>BI-3663 is a selective PTK2/FAK PROTAC with cereblon ligands, degrading PTK2 (IC50: 18 nM), and shows anti-cancer properties.</p>
    Formula:C44H42F3N7O12
    Purity:98%
    Color and Shape:Solid
    Molecular weight:917.84
  • Lck inhibitor 2

    CAS:
    <p>Lck inhibitor 2 blocks tyrosine kinases LCK, BTK, LYN, SYK, TXK with IC50s: Lck 13nM, Btk 9nM/26nM, Lyn 3nM, Txk 2nM.</p>
    Formula:C18H17N5O2
    Color and Shape:Solid
    Molecular weight:335.36
  • Lestaurtinib

    CAS:
    <p>Lestaurtinib (CEP 701) is a FLT3 inhibitor that inhibits the phosphorylation of RPTKs and can be used to study leukemia.</p>
    Formula:C26H21N3O4
    Purity:99.17%
    Color and Shape:Off-White Solid
    Molecular weight:439.46
  • GMB-475

    CAS:
    <p>GMB-475, a PROTAC-based BCR-ABL1 inhibitor, tackles drug resistance by promoting VHL-mediated degradation.</p>
    Formula:C43H46F3N7O7S
    Purity:98.78% - >99.99%
    Color and Shape:Solid
    Molecular weight:861.93
  • Gefitinib-based PROTAC 3

    CAS:
    <p>Gefitinib-PROTAC 3 degrades EGFR in cancer cells; DC50s: 11.7 nM (HCC827) and 22.3 nM (H3255).</p>
    Formula:C47H57ClFN7O8S
    Purity:97.29% - 98.25%
    Color and Shape:Solid
    Molecular weight:934.51
  • Radotinib

    CAS:
    <p>Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably</p>
    Formula:C27H21F3N8O
    Purity:99.13% - 99.97%
    Color and Shape:Solid
    Molecular weight:530.5
  • N-piperidine Ibrutinib

    CAS:
    <p>N-piperidine Ibrutinib is a potent BTK inhibitor with IC50s of 51.0 for WT BTK and 30.7 nM for C481S BTK respectively.</p>
    Formula:C22H22N6O
    Purity:96.65%
    Color and Shape:Solid
    Molecular weight:386.45
  • (Z)-Semaxinib

    CAS:
    <p>(Z)-Semaxinib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor (IC50: 1.23 μM), 20-fold more selective for VEGFR over PDGFRβ, no inhibition for</p>
    Formula:C15H14N2O
    Purity:98.82% - ≥95%
    Color and Shape:Solid
    Molecular weight:238.28
  • 7BIO

    CAS:
    <p>7BIO triggers nonapoptotic death, blocks FLT3, DYRK1A/2, Aurora B/C kinases.</p>
    Formula:C16H10BrN3O2
    Purity:99.67%
    Color and Shape:Solid
    Molecular weight:356.17
  • Protein kinase inhibitor 6

    CAS:
    <p>Protein kinase inhibitor 6 is a protein kinase inhibitor.</p>
    Formula:C13H9FN2S
    Purity:98.01%
    Color and Shape:Solid
    Molecular weight:244.29
  • (E/Z)-Zotiraciclib citrate


    <p>(E/Z)-Zotiraciclib ((E/Z)-TG02) citrate is a potent inhibitor of CDK2, JAK2 and FLT3 and can be used in cancer research.</p>
    Formula:C29H32N4O8
    Color and Shape:Solid
    Molecular weight:564.59
  • Dasatinib N-oxide

    CAS:
    <p>Dasatinib N-oxide is a key metabolite and potential impurity of the kinase inhibitor dasatinib.</p>
    Formula:C22H26ClN7O3S
    Purity:98.54% - 99.94%
    Color and Shape:Solid
    Molecular weight:504
  • UF010

    CAS:
    <p>UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μM and 1.5 μM for HDACs 3, 2, 1 and 8, respectively.</p>
    Formula:C11H15BrN2O
    Purity:98.03% - 99.68%
    Color and Shape:Solid
    Molecular weight:271.15
  • AMG-47a

    CAS:
    <p>AMG-47a inhibits Lck, T cell growth, and degrades KRAS oncoprotein, affecting EGFP-KRASG12V but not EGFP.</p>
    Formula:C29H28F3N5O2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:535.56